What is the Impact Factor of Journal of Experimental & Clinical Cancer Research?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Journal of Experimental & Clinical Cancer Research is 14.3, ranking in quartile Q1 of Web of Science (SCIE).

Is Journal of Experimental & Clinical Cancer Research indexed in Web of Science or Scopus?

Yes, Journal of Experimental & Clinical Cancer Research is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 3.731 (Q1) and an H-index of 152.

Who publishes Journal of Experimental & Clinical Cancer Research and what is the Article Processing Charge (APC)?

Journal of Experimental & Clinical Cancer Research is published by BioMed Central. The estimated Article Processing Charge (APC) is approximately $4,058 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Journal of Experimental & Clinical Cancer Research?

The official ISO-4 abbreviation of Journal of Experimental & Clinical Cancer Research is "J. EXP. CLIN. CANCER RES" with common acronym "jecc". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #490Top JournalHybrid

Journal of Experimental & Clinical Cancer Research

Acronym:jecc

•

Abbreviation (ISO):J. EXP. CLIN. CANCER RES

•

Identifier (ISSN):1756-9966(Print)/0392-9078(Online)

•

Publisher:BioMed Central

Official Website Submission Portal Compare

Clarivate IF (2026)

14.3↑ +1.5

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIETop Tier

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Journal of Experimental & Clinical Cancer Research

WoS Q1

Annual Impact Factor Metric

Current (2026):14.3

Scopus SJR & RankScopus Q1

3.731

#490

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

152

152 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier

Self-Citation Rate1.8%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

342articles/year

99.89% Gold OA•83.11% Original Research

Aims & Scope

Journal of Experimental & Clinical Cancer Research is an online peer-reviewed journal that provides a high-quality forum for all aspects of basic, clinical and translational work in oncology.

Topics Covered (Recognized by AI)

MedicineBiologyGeneticsInternal MedicineChemistryBiochemistryCancer ResearchOncology & Cancer ResearchPathologyImmunologyCell BiologySurgeryOncology

Primary Research Areas

Medicine Oncology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

ONCOLOGY

Rank23/333

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank20/333

IndexSCIE

Category	Index	Rank	Quartile
ONCOLOGY	JCRSCIE	23/333	Q1
ONCOLOGY	JCISCIE	20/333	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF14.3

Articles / Year212

Total Citations165

2025

IF12.8

Articles / Year361

Total Citations3,873

2024

IF11.4

Articles / Year335

Total Citations7,686

2023

IF11.3

Articles / Year347

Total Citations11,912

2022

IF12.658

Articles / Year365

Total Citations20,304

Year	Impact Factor	Articles / Year	Total Citations
2026	14.3	212	165
2025	12.8	361	3,873
2024	11.4	335	7,686
2023	11.3	347	11,912
2022	12.658	365	20,304
2021	11.161	404	24,731
2020	7.068	287	22,743
2019	5.646	506	45,287
2018	6.217	327	30,089
2017	—	194	13,788
2016	—	194	12,651
2015	—	159	10,222

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #490Scopus Q1SCImago Profile

Scopus Coverage:1982-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine

Scopus Citation Rank (SJR)Q1

3.731

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

11.75

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$4,058 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations12,196

3-Year Documents939

Citable Documents930

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate46.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ1

OncologyQ1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 1.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

1区 (Zone 1)Medicine

Minor Category (Specific Field):

1区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Experimental & Clinical Cancer Research (acronym: jecc, abbr: J. EXP. CLIN. CANCER RES, ISSN: 1756-9966) is a peer-reviewed international scholarly journal in the field of Medicine, published by BioMed Central in Italy since 2008. The periodical holds a Journal Impact Factor (JIF) of 14.3, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 3.731 (Q1), an H-index of 152.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 342 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $4,058 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.